<?xml version="1.0" encoding="UTF-8"?>
<p>Secondly, research related to the platform for the immunological response to viral infection and for vaccine development in Korea (Sub-Cluster 1-2) is composed of 39 projects worth 37,045,703 USD. Seoul National University has concentrated their project on “The development of therapeutic antibodies against Middle Eastern respiratory syndrome coronavirus and Zika virus” with spending totaling near 500,000 USD between 2016 and 2021. The International Vaccine Research Institute completed their project, “Discovery of MERS-CoV vaccine Candidate and Evaluation of Vaccine efficacy using in vitro system”, having spent 318,182 USD between 2015 and 2019 (see 
 <xref rid="healthcare-08-00204-t009" ref-type="table">Table 9</xref>).
</p>
